Interestingly, in those RA patients that were responsive to the treatment, expression of Smad7 by the peripheral CD4+ T cells was significantly increased (Figure 3A), which was also accompanied by decreased serum levels of CRP, RF, and DAS28-CRP score (Figures 3B–D). This evidence concerns the gene SMAD7 and rheumatoid arthritis.